TNDM — Tandem Diabetes Care Share News
0.000.00%
- $1.15bn
- $1.30bn
- $1.01bn
US STOCKS ON THE MOVE-SpaceX, Humana, AbbVie
U.S. STOCKS ON THE MOVE-SpaceX, Humana, Crescent Energy
MedTech growth concerns likely to overshadow Q3 results, Leerink says
Tandem Diabetes Care, Inc. reports results for the quarter ended June 30 - Earnings Summary
Tandem Diabetes Care Q2 revenue slightly misses estimates
Brief: Tandem Diabetes Care Inc - Mark Novara, Evp And Chief Commercial Officer, To Be Terminated Without Cause - SEC Filing
Tandem Diabetes Care Q1 net loss narrows
Brief: Tandem Diabetes Care Q1 Gross Margin 55%
Brief: Tandem Diabetes Care’S Control-IQ+ Automated Insulin Delivery Technology Now FDA Cleared For Pregnancy In Type 1 Diabetes
U.S. RESEARCH ROUNDUP- Carnival, Five Below, McKesson
U.S. STOCKS ON THE MOVE -Steel Dynamics, Aldeyra, Cencora
U.S. STOCKS ON THE MOVE-Qualcomm, Canadian Solar, Draftkings
U.S. STOCKS ON THE MOVE-Elbit Systems, Oklo, Janus Henderson
U.S. STOCKS ON THE MOVE-Uber, Honeywell, Delta
Tandem Diabetes rises as Piper Sandler upgrades rating
U.S. STOCKS ON THE MOVE -Viatris, Clear Secure, Bicara
U.S. STOCKS ON THE MOVE-Sharps Technology, Whirlpool, Applovin
U.S. STOCKS ON THE MOVE-Oracle, Vanda, Keysight
Tandem Diabetes steadies after boosted $265 mln convertible bonds sale